Apoptosis in ibuprofen-induced Stevens-Johnson syndrome

Translational Research

Volumn 149, Issue 5, 2007, Pages 254-259

  Neuman, Manuela ^a   Nicar, Michael ^b  

^a MaRS Centre   (Canada)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYTOKINE; FAS ANTIGEN; IBUPROFEN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; AUTHOR; CASE REPORT; CELL ASSAY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CYTOKINE RELEASE; ENZYME ACTIVITY; FEMALE; FEVER; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; LABORATORY; LIVER; LIVER DISEASE; LYMPHOCYTE TOXICITY ASSAY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RASH; RELIABILITY; SKIN; SKIN BIOPSY; STATISTICAL SIGNIFICANCE; STEVENS JOHNSON SYNDROME; SYMPTOM; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS;

EID: 34247349030     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2006.12.005     Document Type: Article

References (29)

1. Gruchalla R.S. Drug metabolism, danger signals, and drug-induced hypersensitivity. J Allergy Clin Immunol 108 (2001) 475-488
2. Moore N., Lecointre D., Noblet C., and Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 45 (1996) 301-308
3. Zimmerman H.J. Hepatotoxicity the adverse effects of drugs and other chemicals on the liver. 2nd ed. (1999), Lippincott Williams and Wilkins, Philadelphia, Pa 498-509
4. Svensson C.K., Cowen E.W., and Gaspari A.A. Cutaneous drug reactions. Pharmcol Rev 53 (2000) 357-379
5. Lazarou J., Pomeranz B., and Corey P. Incidence of adverse drugs reactions in hospitalized patients. JAMA 279 (1998) 1200-1205
6. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 68 (1956) 355-361
7. Lyell A. Toxic epidermal necrolysis (an eruption resembling scalding of the skin) a repraisal. Br J Dermatol 100 (1979) 69-86
8. Bastuji-Garin S., Rzany B., Stern R., Shear N.H., Naldi L., and Roujeau J.C. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiformae. Arch Dermatol 129 (1993) 912-996
9. Knowles S.R., Uetrecht J., and Shear N.H. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet 356 (2000) 1587-1591
10. Park B.K., Pirmohamed M., and Kitteringham N.R. Idiosyncratic drug reactions: a mechanistic evaluation of risk factors. Br J Clin Pharmacol 34 (1992) 377-395
11. Roujeau J.C., and Stern R.S. Severe cutaneous drug reactions to drugs. N Engl J Med 33 (1995) 1600-1607
12. Ring J., and Brockow K. Adverse drug reactions: mechanisms and assessment. Eur Surg Res 34 (2002) 170-175
13. Sharma V.K., Sethuraman G., and Kumar B. Cutaneous drug reactions: clinical pattern and causative agents: a 6 years series from Chandigarh, India. J Postgrad Med 47 (2001) 95-99
14. Neuman M.G., Malkiewicz I.M., and Shear N.H. A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes. Clin Biochem 33 (2000) 517-524
15. Schnyder B., Burkhart C., Shnyder-Frutig K., von Greyerz S., Naisbitt D.J., Pirmohamed M., et al. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. J Immunol 164 (2000) 6647-6654
16. Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 179 (1994) 1529-1537
17. Neuman M.G. Apoptosis in disease of the liver. Crit Rev Clin Lab Sci 38 (2001) 109-166
18. Neuman M.G., Malkiewicz I.M., Phillips E.J., Rachlis A.R., Ong D., Yeung E., and Shear N.H. Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals. Ther Drug Mon 24 (2002) 728-736
19. Neuman M.G., Shear N.H., Bellentani S., and Tiribelli C. Role of cytokines in ethanol-induced hepatotoxicity in Hep G2 cells. Gastroenterology 114 (1998) 157-169
20. Neuman M.G. Apoptosis in liver disease. Rom J Gastroenterol 11 (2002) 3-7
21. Neuman M.G., Cohen L., Gomez M., Fish J., Shear N., and Nicar M. Cytokine network in ibuprofen-induced hepatocytotoxicity. [abstract]. Dig Disease Sci 50 (2005) 10
22. Jules E. Skin biopsy. In: Jules E. (Ed). Immunopathology-a practical approach to diagnosis. 2nd ed. (2003), American Society for Clinical Pathology Press, Chicago, Ill 187-223
23. Abe R., Shimizu T., Shibaki A., Nakamura H., Watanabe H., and Shimizu H. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 162 (2003) 1515-1520
24. Dinarello C. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
25. Tracey K., and Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 9 (1993) 317-343
26. Neuman M.G., Shear N.H., Malkiewicz I.M., and Abbot F. P450's 2E1 inducers trigger valproic acid-induced apoptosis in vitro. Clin Invest Med 21 (1998) 582
27. Neuman M.G., Cameron R.G., Shear N.H., and Feuer G. Drug-induced apoptosis of skin cells and liver. In: Cameron R.G., and Fauer G. (Eds). Handbook of experimental pharmacology: apoptosis modulation by drugs vol. 142 (1999), Springer Verlag, Heidelberg 344-355
28. Caproni M., Antiga E., Parodi A., Schena D., Marzano A., Quaglino P., et al. Elevated circulating CD40 ligand in patients with erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum. Br J Dermatol 154 (2006) 1006-1007
29. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., and Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22 (2004) 929-979